Description of original award (Fiscal Year 2021, $549,991)
We are requesting Enhancement funding to serve the mostly rural parish of Terrebonne which as of 2020 holds a population of approximately 111,860. We are a post-adjudication court and the funds are being requested to serve our Adult Drug Court (ADC) program. We are requesting $500,000 for the life of this grant. The number of participants expecting to be served over the life of this grant is 204. The minimum length of stay in the program is 18 months, the maximum is 36 months, and the average length of stay is estimated at 32 months. We look to serve the HR/HN population and the criminogenic risk and treatment need will be captured utilizing the Risk and Need Triage (RANT) tool. A complete assessment, using the ASI, MAST, and DAST, is conducted immediately after a participant’s plea into the drug court program. There is a sufficient medical community to oversee MAT in this jurisdiction. In the more recent years, there has been an increase in participants with opioid use disorder. Our OJP/BJA Grant (2019-DC-BX-0041) allows our opioid participants to receive MAT services using Naltrexone (Vivitrol) throughout their treatment stay. We provide other EBT services such as Moral Reconation Therapy (MRT), Motivational Interviewing (MI), and Seeking Safety to help address the other substance use disorders (SUD). The proposed project will address standards #s 1, 6, and 7 as indicated on page 8 of the project narrative. We are in the final month (No-Cost Extension) of our 2017 SAMHSA Grant (1H79TI080156-01) which has provided childcare and transportation assistance for our participants, along with the implementation of the Double-Trouble in Recovery, Family/Couple Counseling, and Peer Recovery Support Leader programs. Our OJP/BJA Grant (2019-DC-BX-0041) addresses MAT and MRT services. The only other current federal funding source is TANF. The TPDTC received an OJP/BJA Grant (2016-DC-BX-0069) in 2016. We are not leveraging any other federal funding source at this time.